Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Ebie in connection with a capital raising
Mandate

Vinge advises Ebie in connection with a capital raising

May 17, 2024 M&A

Vinge has advised the proptech company Ebie (Rentfair AB) in connection with a capital raising of SEK 8 million to further expand the business.

Ebie distributes an insurance solution in the form of a rental guarantee which frees up capital for companies that rent premises and would otherwise have had to tie up the money in a deposit or bank guarantee. The company was founded by Ville Löthén, Edvin Lindhout, Erik Larsson and André Brogärd and has experienced strong growth in recent years.

The round was led by Belgian proptech fund AMAVI Capital and also included several new and existing investors, including SSE Ventures.

Vinge's team consisted of Filip Öhrner and Tim Axell.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026